Learn more

METABASIS THERAPEUTICS INC

Overview
  • Total Patents
    328
  • GoodIP Patent Rank
    58,197
  • Filing trend
    ⇩ 44.0%
About

METABASIS THERAPEUTICS INC has a total of 328 patent applications. It decreased the IP activity by 44.0%. Its first patent ever was published in 1991. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ITALCHEMI SPA, ACAD OF SCIENCE CZECH REPUBLIC and INOLOGIC INC.

Patent filings per year

Chart showing METABASIS THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Erion Mark D 154
#2 Reddy K Raja 109
#3 Dang Qun 104
#4 Hecker Scott J 60
#5 Boyer Serge H 52
#6 Sun Zhili 49
#7 Kasibhatla Srinivas Rao 46
#8 Li Haiqing 42
#9 Lemus Robert Huerta 41
#10 Nguyen Thanh Huu 41

Latest patents

Publication Filing date Title
US2017319604A1 Thyroid hormone receptor agonist and use thereof
WO2011038207A1 Phosphorus-containing thyroid hormone receptor agonists and methods of use
EP2805951A2 Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof
WO2010093601A1 Novel sulfonic acid-containing thyromimetics, and methods for their use
CN102292316B Glucagon antagonists
TW200936146A Antiviral nucleoside compounds
MX2010001784A Novel activators of glucokinase.
WO2009012039A2 Crystalline polymorphs
CN105566265A Antagonists of the glucagon receptor
WO2008019309A1 Novel inhibitors of fructose 1,6-bisphosphatase
WO2007081755A2 Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
AU2006202624A1 Novel bisamidate phosphonate prodrugs
CN101189248A Novel phosphorus-containing thyromimetics
US2009232879A1 Thyromimetics for the Treatment of Fatty Liver Diseases
AU2006249348A1 Novel phosphinic acid-containing thyromimetics
CN101180097A Novel phosphinic acid-containing thyromimetics
US2008070867A1 2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases
AU2005227362A1 Novel aryl fructose-1, 6-bisphosphatase inhibitors
EP1841749A1 Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
EP1778250A2 Novel thiazole inhibitors of fructose 1,6-bisphosphatase